Xeris Biopharma Holdings, Inc. (XERS)
5.81
-0.23
(-3.81%)
USD |
NASDAQ |
Mar 06, 16:00
5.81
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Cash from Investing (TTM) : -0.696M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 69.76M |
| Zoetis, Inc. | -748.00M |
| Harrow, Inc. | -5.46M |
| Zymeworks, Inc. | 26.72M |
| Vir Biotechnology, Inc. | 310.37M |